Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

654 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New questions about transplantation in multiple myeloma.
Hari P, Pasquini MC, Vesole DH. Hari P, et al. Oncology (Williston Park). 2006 Sep;20(10):1230-42; discussion 1242, 1244, 1249-50. Oncology (Williston Park). 2006. PMID: 17024872 Free article. Review.
Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.
Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M. Dhakal B, et al. Biol Blood Marrow Transplant. 2014 Dec;20(12):1926-31. doi: 10.1016/j.bbmt.2014.08.002. Epub 2014 Aug 8. Biol Blood Marrow Transplant. 2014. PMID: 25111581 Free article. Clinical Trial.
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P. D'Souza A, et al. Among authors: hari p. Br J Haematol. 2017 Sep;178(5):816-819. doi: 10.1111/bjh.14170. Epub 2016 Jun 13. Br J Haematol. 2017. PMID: 27292583 Free PMC article. No abstract available.
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.
Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M. Dhakal B, et al. Among authors: hari p. Biol Blood Marrow Transplant. 2016 Oct;22(10):1773-1780. doi: 10.1016/j.bbmt.2016.06.016. Epub 2016 Jun 21. Biol Blood Marrow Transplant. 2016. PMID: 27345140 Free article.
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazarus H, Lee C, Maziarz RT, Meehan K, Mikhael J, Nishihori T, Ramanathan M, Usmani S, Tay J, Vesole D, Wirk B, Yared J, Savani BN, Gasparetto C, Krishnan A, Mark T, Nieto Y, D'Souza A. Scott EC, et al. Among authors: hari p. Biol Blood Marrow Transplant. 2016 Oct;22(10):1893-1899. doi: 10.1016/j.bbmt.2016.07.007. Epub 2016 Aug 2. Biol Blood Marrow Transplant. 2016. PMID: 27496215 Free PMC article.
654 results